OUR SPEAKERS

Safiya Abouzaid, PharmD, MPH

Johnson & Johnson

Vice President, Value, Access, Pricing & Health Care Policy

Edward "Ted" Arrowsmith, BSc, DC, BSN, MSN-RN, CLSSBB, CPHQ

Executive Vice President for Therapeutics with Tennessee Oncology and Medical Director for Pathways with Oneoncology

Tennessee Oncology

Johnetta Blakely, MD, MS, MMHC

Executive VP of Quality and Clinc Operations

Tennessee Oncology

Sibel Blau, MD

President and CEO

ONCare Alliance, LLC

Anthony Boyd, PharmD, BCPS

Senior Pharmacy Director

Cleveland Clinic

Kristen Boykin, PharmD, BCOP, BCPS

Director of Pharmacy Operations

Florida Cancer Institute and Research Specialists

Casey Chiasson

Executive Director

Wilamette Valley Cancer Institute

Davey Daniel, MD

Chief Medical Officer

OneOncology

Fred Divers, MD

Chief Medical Officer

American Oncology Network

David Eagle, MD

Chair of Legislative Affairs and Patient Advocacy

New York Cancer & Blood Specialists

Josh Eaves

Chief Development and Strategy Officer

Florida Cancer Specialists & Research Institute

Daniel Efiom-Ekaha, MD, FACP

Hematology/Oncology Physician

Cancer Care Associates of York

Mark Fendrick, MD

Director, Center for Value-Based Insurance Design

University of Michigan

Paul Forsberg, MD, MS

Sr. Director of Pharmacy Solutions

US Oncology Network

Scott Freeswick, MS, PharmD

Chief Pharmacy Officer

Memorial Sloan Kettering

Danielle Geiger MSN, APRN-NP

Chief Operating Officer

Nebraska Cancer Specialists

Ryan Haumschild, PharmD, MS, MBA, CPEL

Vice President of Ambulatory Pharmacy

Emory Healthcare and Winship Cancer Institute of Emory University

Rhonda Henschel, MBA

Senior Vice President, Payer and Care Transformation

US Oncology Network

Sophia Humphreys, PharmD, MHA, BCBBS

Executive Director of Pharmacy,

Providence Health

Jeff Hunnicutt

Chief Executive Officer

Highlands Oncology

Puneeth Indurlal, MD, MS

Vice President, Practice Operations

American Oncology Network

Clayton Irvine, PharmD, MBA, MS

Senior Manager, Oncology Cancer Care

Mayo Clinic

David Jackman, MD

Medical Director, Clinical Pathways and New Business Initiatives

Dana-Farber Cancer Institute

David Johnson, MD, MPH

Chief Physician Executive

Atlas Oncology Partners

Ben Jones

Vice President, Government Relations and Public Policy

US Oncology Network

Brian Koffman, MD

Executive Vice President and Chief Medical Officer

CLL Society, Inc

James Lee

Director of State Regulation & Policy

Community Oncology Alliance (COA)

Edward J. Licitra, MD, PhD

Chief Executive Officer

Astera Health Partners/Astera Cancer Care

Bryan Loy, MD, MBA

Corporate Medical Director

Humana

Aaron Lyss

Senior Director Payment and Policy Innovation

OneOncology

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics

University of Kansas Cancer Center

Barbara McAneny, MD

Chief Executive Officer

New Mexico Oncology Hematology Consultants Ltd.

Timothy Mok, PharmD, BCOP, BCPS

Manager and Assistant Clinical Professor

Kaiser Permanente & UCSF School of Pharmacy

Kathy Oubre, MS

Chief Executive Officer

Pontchartrain Cancer Center

Kathryn Paliotta, RN

VP Patient Communication

NY Cancer and Blood Specialists

Lisa Raff, PharmD, MSPharm, BCPS, BCOP

Vice President of Pharmacy Services

OneOncology

Barry Russo, MBA

CEO

The Center for Cancer and Blood Disorders

Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC

Vice President of Clinical Innovation

American Oncology Network

Alyssa Schatz, MSW

Vice President, Policy and Advocacy

National Comprehensive Cancer Network

Tom Snow, MBA

General Manager, US Oncology

Sanofi

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Director, Pharmacy Cancer Care

Mayo Clinic

Stephen Speicher, MD, MS

Senior Medical Director, Head of Healthcare Quality and Patient Safety

Flatiron Health

Tracy Spinks

Director Value-based Care

Optum

Stuart Staggs, MSIE

Vice President, Transformation and Shared Services

McKesson

Peter Stetson, MD, MA

Chair of NCCN’s EHR Oncology Advisory Group

NCCN

Vivek Subbiah, MD

Chief, Early-Phase Drug Development

Sarah Cancer Research Institute

Jonathan Tinker

Vice President Oncology Services

Sarah Cannon Cancer Network

Emily Touloukian, DO

President and CEO

Coastal Cancer Center

Jeff Vacirca, MD

CEO

NY Cancer and Blood Specialists

John L. Villano, MD, PhD

Director, Clinical Neuro-Oncology

University of Kentucky

Dan Virnich, MD, MBA, FACHE

CEO

The Oncology Institute

Lalan Wilfong, MD

Senior Vice President, Value Based Care

Thyme Care

Bruce Wilson

VP, US Oncology Care and Access

AstraZeneca

OUR SPEAKERS

Our Speakers